![Liver-MRI-768x244](https://content.labcorp.com//sites/default/files/2024-02/liver-mri-768x244.png)
Leveraging the Clinical Power of MRI in Preclinical Liver Tumor Imaging
![](https://content.labcorp.com/sites/default/files/2024-02/lab-work-1020x600.jpg)
The liver is an ideal organ for magnetic resonance imaging (MRI) due to its size, plus the inherent contrast it enables compared to other tissues and lesions; this results from the high iron content which acts as a natural MRI contrast agent. For such reasons, liver tumor MRI is a major area of clinical and preclinical oncology imaging. We have been performing liver tumor MRI for over a decade to evaluate mouse syngeneic intrasplenic liver metastasis models, orthotopic human tumor xenografts (PDXs), and GEM models. Liver tumor MRI facilitates use of models with more clinically relevant context, enabling:
![Liver-MRI-768x244](https://content.labcorp.com//sites/default/files/2024-02/liver-mri-768x244.png)
MRI can maximize chances of successful clinical translation for novel liver tumor therapies. Contact us to learn more and to obtain example data.